Ajanta Pharma Limited Ajanta Pharma Limited

Ajanta Pharma Limited

AJANTPHARM

Rankning i aktier #3733
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Aktiekurs
$35.98
Marknadsvärde
$4.50B
Förändring (1 dag)
-1.18%
Förändring (1 år)
29.38%
Land
IN
Handel Ajanta Pharma Limited (AJANTPHARM)

Kategori

Healthcare
Vinst för Ajanta Pharma Limited (AJANTPHARM)
Vinst i Jun 2026 TTM: $164.80M
Enligt de senaste finansiella rapporterna från Ajanta Pharma Limited är företagets nuvarande vinst $164.80M. År 2024 hade företaget en vinst på $133.59M, en ökning jämfört med vinsten år 2023 som var $90.68M. Vinsten som visas på denna sida är vinsten före räntor och skatt, även kallad EBIT.
Vinshistorik för Ajanta Pharma Limited från 2005 till 2026
Vinst vid slutet av varje år
År Vinst Ändra
2026 (TTM) $164.80M 18.53%
2025 $139.04M 4.08%
2024 $133.59M 47.31%
2023 $90.68M -24.31%
2022 $119.81M -2.57%
2021 $122.97M 39.52%
2020 $88.14M 19.01%
2019 $74.06M -22.54%
2018 $95.62M -4.34%
2017 $99.95M 20.97%
2016 $82.63M 13.06%
2015 $73.08M 32.80%
2014 $55.03M 69.13%
2013 $32.54M 81.39%
2012 $17.94M 41.32%
2011 $12.69M 47.07%
2010 $8.63M 46.96%
2009 $5.87M -18.63%
2008 $7.22M 61.49%
2007 $4.47M 39.66%
2006 $3.20M 48.67%
2005 $2.15M 0.00%
Vinst för liknande företag eller konkurrenter